Sign inJoin waitlistJoin the waitlist

Marco Mielcarek

Training Site Director | Blood & Marrow Transplantation · University of Washington School of Medicine

Credentials: · · · · ·

History

Adult Blood and Marrow Transplant Program · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

University of Washington-Seattle Campus
1989–1991
Internal Medicine
1986–1989
Doctor of Medicine
1982–1986

Research

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Blood · 2011 · 552 citations
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
Blood · 2003 · First of 8 authors · Corresponding · 432 citations
Cord-Blood Transplantation in Patients with Minimal Residual Disease
New England Journal of Medicine · 2016 · 380 citations

Rainer Storb
57 papers
Brenda Sandmaier
39 papers
Paul Martin
29 papers
David Maloney
22 papers
Mary Flowers
22 papers
Frederick Appelbaum
21 papers
Michael Boeckh
17 papers
TC
Thomas Chauncey
15 papers
Joachim Deeg
12 papers
MM
Michael Maris
12 papers
Steven Pergam
11 papers
Mohamed Sorror
10 papers

Grants

Optimizing the Dosing of Post-Transplantation Cyclophosphamide for Peripheral Blood Stem Cell Transplantation
National Cancer Institute · U01
Contact PI · $695.2K · Fred Hutchinson Cancer Center
2026–2031
Statins for Prevention of GVHD
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.2M · Fred Hutchinson Cancer Research Center
2011–2017
Radiation Dose-Dependent Interventions
National Institute of Allergy and Infectious Diseases · U19
Project lead · $2.2M · Fred Hutchinson Cancer Research Center
2005–2012
Optimizing Nonmyeloablative Stem Cell Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $641.3K · Fred Hutchinson Cancer Research Center
2003–2008

Clinical trials

A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD
Principal investigator · Withdrawn · Phase 2
AbGenomics B.V Taiwan Branch
2016–2018
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2012–2019
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2012–2016
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2011–2015